Cancer: Solid Tumours Menu
In October 2020, the latest version of the National Test Directory (NTD) for Cancer was published by NHSE; this sets out the national strategy for the genomic tests that are available for cancer diagnostics tests and the technologies by which testing will be delivered.
The NE&Y GLH solid tumour service is delivered by a regional team across the three genomic laboratory services. Details on how to order a test are described below.
Cancer genomics diagnostics are funded centrally by NHSE and so referring Trusts will not be charged for these services if they refer testing to their designated local GLH.